INOVIO PHARMACEUTICALS, INC. Interest Expense Operating
INOVIO PHARMACEUTICALS, INC. (INO) reported Interest Expense Operating of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOperating · last filed 2024-08-08
- INOVIO PHARMACEUTICALS, INC. interest expense operating for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest expense operating for the quarter ending 2023-06-30 was $313.49K.
| Period end | Interest Expense Operating 3 month | Interest Expense Operating 6 month |
|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $177.83K 10-Q · filed 2024-08-08 |
| 2023-06-30 | $313.49K 10-Q · filed 2024-08-08 | $626.98K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |